InHANSE Institute of Head and Neck Studies and Education Contact Us

Professor Mehanna presents the DeESCALaTE HPV study findings

Professor Mehanna presented the findings of the De-ESCALaTE HPV study at European Society for Medical Oncology (ESMO), which was held in Munich from the 19th October to the 23rd.  The study showed a significantly higher 2-year survival in HPV positive oropharyngeal cancer patients receiving chemoradiation vs cetuximab and radiation.  More details are available from the ESMO press office.

Charity appeal

Find out more about our £1m Charity appeal for the AcceleraTED cancer Treatment programme.